If this file is a laboratory or reference update, it likely addresses the ongoing challenges in :
The medical context for PTH at that time was dominated by the results of the clinical trial, which presented significant long-term efficacy and safety data in mid-2022.
Documents or data files from May 2022 often contain results from the trial, which evaluated TransCon PTH (palopegteriparatide) for adults with hypoparathyroidism. Key findings shared around this time included:
2022: 05 13 Pth Actualizat.rar
If this file is a laboratory or reference update, it likely addresses the ongoing challenges in :
The medical context for PTH at that time was dominated by the results of the clinical trial, which presented significant long-term efficacy and safety data in mid-2022. 2022 05 13 PTh actualizat.rar
Documents or data files from May 2022 often contain results from the trial, which evaluated TransCon PTH (palopegteriparatide) for adults with hypoparathyroidism. Key findings shared around this time included: If this file is a laboratory or reference
